195 related articles for article (PubMed ID: 28390392)
21. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
Zhang J; Jima D; Moffitt AB; Liu Q; Czader M; Hsi ED; Fedoriw Y; Dunphy CH; Richards KL; Gill JI; Sun Z; Love C; Scotland P; Lock E; Levy S; Hsu DS; Dunson D; Dave SS
Blood; 2014 May; 123(19):2988-96. PubMed ID: 24682267
[TBL] [Abstract][Full Text] [Related]
22. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.
Hakimi AA; Ostrovnaya I; Reva B; Schultz N; Chen YB; Gonen M; Liu H; Takeda S; Voss MH; Tickoo SK; Reuter VE; Russo P; Cheng EH; Sander C; Motzer RJ; Hsieh JJ;
Clin Cancer Res; 2013 Jun; 19(12):3259-67. PubMed ID: 23620406
[TBL] [Abstract][Full Text] [Related]
23. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
[TBL] [Abstract][Full Text] [Related]
24. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel genetic and epigenetic regulators of different tissue types of cervical cancer.
Chandra S; Sarkar S; Mandal P
J Obstet Gynaecol Res; 2022 Dec; 48(12):3179-3190. PubMed ID: 36184073
[TBL] [Abstract][Full Text] [Related]
26. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome.
Ng SB; Bigham AW; Buckingham KJ; Hannibal MC; McMillin MJ; Gildersleeve HI; Beck AE; Tabor HK; Cooper GM; Mefford HC; Lee C; Turner EH; Smith JD; Rieder MJ; Yoshiura K; Matsumoto N; Ohta T; Niikawa N; Nickerson DA; Bamshad MJ; Shendure J
Nat Genet; 2010 Sep; 42(9):790-3. PubMed ID: 20711175
[TBL] [Abstract][Full Text] [Related]
27. USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma.
Wu Y; Gu H; Bao Y; Lin T; Wang Z; Gu D; Shen H; Xian H; Fan Y; Mao R
Cell Biochem Funct; 2022 Jun; 40(4):379-390. PubMed ID: 35411950
[TBL] [Abstract][Full Text] [Related]
28. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.
Yeh CH; Bai XT; Moles R; Ratner L; Waldmann TA; Watanabe T; Nicot C
Mol Cancer; 2016 Feb; 15():15. PubMed ID: 26880370
[TBL] [Abstract][Full Text] [Related]
29. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Li C; Ke J; Liu J; Su J
J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
Li D; Liu SH; Liu QY; Zou QQ; Lv L; Liu GL; Wu Y
Cancer Biother Radiopharm; 2021 Aug; 36(6):511-520. PubMed ID: 32589477
[No Abstract] [Full Text] [Related]
32. HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.
Groves IJ; Knight EL; Ang QY; Scarpini CG; Coleman N
Oncogene; 2016 Sep; 35(36):4773-86. PubMed ID: 26876196
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women.
Li X; Huang H; Guan Y; Gong Y; He CY; Yi X; Qi M; Chen ZY
Cancer Med; 2017 Jan; 6(1):207-219. PubMed ID: 27998038
[TBL] [Abstract][Full Text] [Related]
34. Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.
Maliekal TT; Antony ML; Nair A; Paulmurugan R; Karunagaran D
Oncogene; 2003 Jul; 22(31):4889-97. PubMed ID: 12894231
[TBL] [Abstract][Full Text] [Related]
35. Mutation spectrum of MLL2 in a cohort of Kabuki syndrome patients.
Micale L; Augello B; Fusco C; Selicorni A; Loviglio MN; Silengo MC; Reymond A; Gumiero B; Zucchetti F; D'Addetta EV; Belligni E; Calcagnì A; Digilio MC; Dallapiccola B; Faravelli F; Forzano F; Accadia M; Bonfante A; Clementi M; Daolio C; Douzgou S; Ferrari P; Fischetto R; Garavelli L; Lapi E; Mattina T; Melis D; Patricelli MG; Priolo M; Prontera P; Renieri A; Mencarelli MA; Scarano G; della Monica M; Toschi B; Turolla L; Vancini A; Zatterale A; Gabrielli O; Zelante L; Merla G
Orphanet J Rare Dis; 2011 Jun; 6():38. PubMed ID: 21658225
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning.
Huang J; Qian Z; Gong Y; Wang Y; Guan Y; Han Y; Yi X; Huang W; Ji L; Xu J; Su M; Yuan Q; Cui S; Zhang J; Bao C; Liu W; Chen X; Zhang M; Gao X; Wu R; Zhang Y; Xu H; Zhu S; Zhu H; Yang L; Xu X; Zhou P; Liang Z
J Med Genet; 2019 Mar; 56(3):186-194. PubMed ID: 30567904
[TBL] [Abstract][Full Text] [Related]
37. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.
Zhang L; Tian S; Pei M; Zhao M; Wang L; Jiang Y; Yang T; Zhao J; Song L; Yang X
Oncol Rep; 2019 Dec; 42(6):2655-2669. PubMed ID: 31661141
[TBL] [Abstract][Full Text] [Related]
40. Whole-exome and RNA sequencing reveal novel insights into the pathogenesis of HPV associated cervical cancer.
Wu Y; Zhao J; Dong S; Wang Y; Li A; Jiang Y; Chen Z; Li C; Wang W; Zhang Z
Cancer Biomark; 2019; 25(4):341-350. PubMed ID: 31306105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
